MedPath

Digital Glucose Monitoring in Gestational Diabetes

Not Applicable
Conditions
Gestational Diabetes
Interventions
Other: glucose buddy application
Registration Number
NCT02783612
Lead Sponsor
Wolfson Medical Center
Brief Summary

Assessing blood glucose control in women with gestational diabetes can be challenging. The standard of care remains visual inspection of blood glucose paper diaries of self-performed capillary monitoring during regular meeting in High Risk pregnancy clinics.

The researchers are interested in preforming a randomized control trial comparing women with the diagnosis of gestational diabetes with regular High-Risk clinic surveillance to digital monitoring using an application in a Smart-phone and submitting those values via email in addition to the regular clinic appointments.

The Primary outcome of the trial is to assess the compliance of the research group as compared to the control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • gestational diabetes
Exclusion Criteria
  • pre-gestational diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
glucose applicationglucose buddy applicationRegular high risk pregnancy clinic surveillance in addition to a Smart phone application for registering the Blood glucose levels and submitting via email every 3-5 days to the High risk Doctor involved in the trial.
Primary Outcome Measures
NameTimeMethod
Assessing the compliance of the research group compared to the control group.18 month

By calculating the amount of daily glucose measurements in the research group compared to the number of glucose measurements in the control group

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wolfson medical center

🇮🇱

Holon, Israel

© Copyright 2025. All Rights Reserved by MedPath